Skip to navigation Skip to content
  • Woodruff
  • Business
  • Health Sciences
  • Law
  • Rose
  • Oxford College
  • Theology
  • Schools
    • Undergraduate

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing

      Community

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing
    • Graduate

      • Business School
      • Graduate School
      • School of Law
      • School of Medicine
      • School of Nursing
      • School of Public Health
      • School of Theology
  • Libraries
    • Libraries

      • Robert W. Woodruff
      • Business
      • Chemistry
      • Health Sciences
      • Law
      • MARBL
      • Music & Media
      • Oxford College
      • Theology
    • Library Tools

      • Course Reserves
      • Databases
      • Digital Scholarship (ECDS)
      • discoverE
      • eJournals
      • Electronic Dissertations
      • EmoryFindingAids
      • EUCLID
      • ILLiad
      • OpenEmory
      • Research Guides
  • Resources
    • Resources

      • Administrative Offices
      • Emory Healthcare
      • Academic Calendars
      • Bookstore
      • Campus Maps
      • Shuttles and Parking
      • Athletics: Emory Eagles
      • Arts at Emory
      • Michael C. Carlos Museum
      • Emory News Center
      • Emory Report
    • Resources

      • Emergency Contacts
      • Information Technology (IT)
      • Outlook Web Access
      • Office 365
      • Blackboard
      • OPUS
      • PeopleSoft Financials: Compass
      • Careers
      • Human Resources
      • Emory Alumni Association
  • Browse
    • Works by Author
    • Works by Journal
    • Works by Subject
  • For Authors
    • How to Submit
    • Deposit Advice
    • Deposit Instructions
    • Author Rights
    • FAQ
    • Emory Open Access Policy
    • Open Access Fund
  • About OpenEmory
    • About OpenEmory
    • About Us
    • Citing Articles
    • Contact Us
    • Privacy Policy
    • Terms of Use
 
Contact Us

Filter Results:

Year

  • 2016 (1)
  • 2017 (1)
  • 2019 (1)
  • 2020 (1)

Author

  • Chen, Guangping (2)
  • Chen, Ching-Wen (1)
  • Chen, Hong-Ru (1)
  • Du, Jie (1)
  • Hou, R. (1)
  • Klein, Janet D (1)
  • Kong, X. (1)
  • Kuan, Chia-Yi (1)
  • Liu, Bi-Cheng (1)
  • Mandhani, Nandita (1)
  • Naqvi, Nawazish (1)
  • Qian, Xiaoqian (1)
  • Sands, Jeff (1)
  • Short-Miller, Jonah C (1)
  • Smucker, Marchelle R (1)
  • Song, Xiang (1)
  • Sun, Yu-Yo (1)
  • Tan, Lin (1)
  • Wang , Bin (1)
  • Wang, Haidong (1)
  • Wang, Xiaonan (1)
  • Wang, Ze-Mu (1)
  • Xie, Y. (1)
  • Yang, B. (1)
  • Zhang, Ainqing (1)

Subject

  • Health Sciences, Medicine and Surgery (2)
  • Biology, Cell (1)
  • Biology, Physiology (1)
  • Health Sciences, General (1)
  • Health Sciences, Immunology (1)
  • Health Sciences, Pharmacology (1)

Journal

  • Clinical and Translational Oncology (1)
  • Journal of Neuroscience (1)
  • Pflügers Archiv European Journal of Physiology (1)
  • Theranostics (1)

Keyword

  • biomedicin (3)
  • life (3)
  • scienc (3)
  • technolog (3)
  • activ (2)
  • c (2)
  • concentr (2)
  • mice (2)
  • transport (2)
  • urea (2)
  • ut (2)
  • utb (2)
  • 2 (1)
  • 57 (1)
  • accumul (1)
  • anim (1)
  • apoptosi (1)
  • associ (1)
  • atrophi (1)
  • autism (1)
  • autist (1)
  • behavior (1)
  • bl (1)
  • bladder (1)
  • bladdercanc (1)
  • blood (1)
  • bloodgroup (1)
  • brain (1)
  • cancer (1)
  • cardiomyopathi (1)
  • cell (1)
  • cellcycl (1)
  • collect (1)
  • control (1)
  • cycl (1)
  • densiti (1)
  • development (1)
  • disabl (1)
  • disord (1)
  • duct (1)
  • experiment (1)
  • express (1)
  • factor (1)
  • failur (1)
  • femal (1)
  • gene (1)
  • genom (1)
  • genomewid (1)
  • glycosyl (1)
  • group (1)
  • heart (1)
  • heartfailur (1)
  • hypoxia (1)
  • i (1)
  • ic (1)
  • immun (1)
  • inbr (1)
  • insulin (1)
  • insulinresist (1)
  • interact (1)
  • invas (1)
  • ischemia (1)
  • kappa (1)
  • kidd (1)
  • kinas (1)
  • lack (1)
  • lamp (1)
  • macrophag (1)
  • male (1)
  • matern (1)
  • mechan (1)
  • medicin (1)
  • membran (1)
  • metabol (1)
  • metformin (1)
  • microglia (1)
  • molecular (1)
  • molecularmechan (1)
  • monocyt (1)
  • muscl (1)
  • myogenesi (1)
  • neurodevelopment (1)
  • neuroimmun (1)
  • nf (1)
  • nfkappa (1)
  • oncolog (1)
  • parvalbumin (1)
  • peptid (1)
  • phosphoryl (1)
  • physiolog (1)
  • poli (1)
  • post (1)
  • postsynapt (1)
  • potenti (1)
  • pregnanc (1)
  • protein (1)
  • research (1)
  • resist (1)

Author department

  • Physiology: Admin (2)
  • Medicine: Cardiology (1)
  • Medicine: Nephrology (1)
  • Peds: Neuro & Neuropsych (1)

Search Results for all work with filters:

  • b
  • defect

Work 1-4 of 4

Sorted by relevance

Article

SLC14A1: a novel target for human urothelial cancer

by R. Hou; X. Kong; B. Yang; Y. Xie; Guangping Chen

2017

Subjects
  • Health Sciences, Pharmacology
  • Health Sciences, General
  • File Download
  • View Abstract

Abstract:Close

Urinary bladder cancer is the second commonly diagnosed genitourinary malignancy. Previously, bio-molecular alterations have been observed within certain locations such as chromosome 9, retinoblastoma gene and fibroblast growth factor receptor-3. Solute carrier family 14 member 1 (SLC14A1) gene encodes the type-B urea transporter (UT-B) which facilitates the passive movement of urea across cell membrane, and has recently been related with human malignancies, especially for bladder cancer. Herein, we discussed the SLC14A1 gene and UT-B protein properties, aiming to elucidate the expression behavior of SLC14A1 in human bladder cancer. Furthermore, by reviewing some well-established theories regarding the carcinogenesis of bladder cancer, including several genome wide association researches, we have bridged the mechanisms of cancer development with the aberrant expression of SLC14A1. In conclusion, the altered expression of SLC14A1 gene in human urothelial cancer may implicate its significance as a novel target for research.

Article

Modulation of kidney urea transporter UT-A3 activity by alpha2,6-sialylation

by Xiaoqian Qian; Jeff Sands; Xiang Song; Guangping Chen

2016

Subjects
  • Biology, Physiology
  • Biology, Cell
  • File Download
  • View Abstract

Abstract:Close

Two urea transporters, UT-A1 and UT-A3, are expressed in the kidney terminal inner medullary collecting duct (IMCD) and are important for the production of concentrated urine. UT-A1, as the largest isoform of all UT-A urea transporters, has gained much attention and been extensively studied; however, the role and the regulation of UT-A3 are less explored. In this study, we investigated UT-A3 regulation by glycosylation modification. A site-directed mutagenesis verified a single glycosylation site in UT-A3 at Asn279. Loss of the glycosylation reduced forskolin-stimulated UT-A3 cell membrane expression and urea transport activity. UT-A3 has two glycosylation forms, 45 and 65 kDa. Using sugar-specific binding lectins, the UT-A3 glycosylation profile was examined. The 45-kDa form was pulled down by lectin concanavalin A (Con A) and Galant husnivalis lectin (GNL), indicating an immature glycan with a high amount of mannose (Man), whereas the 65-kDa form is a mature glycan composed of acetylglucosamine (GlcNAc) and poly-N-acetyllactosame (poly-LacNAc) that was pulled down by wheat germ agglutinin (WGA) and tomato lectin, respectively. Interestingly, the mature form of UT-A3 glycan contains significant amounts of sialic acid. We explored the enzymes responsible for directing UT-A3 sialylation. Sialyltransferase ST6GalI, but not ST3GalIV, catabolizes UT-A3 α2,6-sialylation. Activation of protein kinase C (PKC) by PDB treatment promoted UT-A3 glycan sialylation and membrane surface expression. The PKC inhibitor chelerythrine blocks ST6GalI-induced UT-A3 sialylation. Increased sialylation by ST6GalI increased UT-A3 protein stability and urea transport activity. Collectively, our study reveals a novel mechanism of UT-A3 regulation by ST6GalI-mediated sialylation modification that may play an important role in kidney urea reabsorption and the urinary concentrating mechanism.

Article

Monocytic infiltrates contribute to autistic-like behaviors in a two-hit model of neurodevelopmental defects

by Hong-Ru Chen; Ching-Wen Chen; Nandita Mandhani; Jonah C Short-Miller; Marchelle R Smucker; Yu-Yo Sun; Chia-Yi Kuan

2020

Subjects
  • Health Sciences, Medicine and Surgery
  • Health Sciences, Immunology
  • File Download
  • View Abstract

Abstract:Close

Growing evidence suggests that early-life interactions among genetic, immune, and environment factors may modulate neurodevelopment and cause psycho-cognitive deficits. Maternal immune activation (MIA) induces autism-like behaviors in offspring, but how it interplays with perinatal brain injury (especially birth asphyxia or hypoxia ischemia [HI]) is unclear. Herein we compared the effects of MIA (injection of poly[I:C] to dam at gestational day 12.5), HI at postnatal day 10, and the combined MIA/HI insult in murine offspring of both sexes. We found that MIA induced autistic-like behaviors without microglial activation but amplified post-HI NFjB signaling, pro-inflammatory responses, and brain injury in offspring. Conversely, HI neither provoked autistic-like behaviors nor concealed them in the MIA offspring. Instead, the dual MIA/HI insult added autistic-like behaviors with diminished synaptic density and reduction of autism-related PSD-95 and Homer-1 in the hippocampus, which were missing in the singular MIA or HI insult. Further, the dual MIA/HI insult enhanced the brain influx of Otx2-positive monocytes that are associated with an increase of perineuronal net-enwrapped parvalbumin neurons. Using CCR2-CreER mice to distinguish monocytes from the resident microglia, we found that the monocytic infiltrates gradually adopted a ramified morphology and expressed the microglial signature genes (Tmem119, P2RY12, and Sall1) in post-MIA/HI brains, with some continuing to express the proinflammatory cytokine TNFa. Finally, genetic or pharmacological obstruction of monocytic influx significantly reduced perineuronal net-enwrapped parvalbumin neurons and autistic-like behaviors in MIA/HI offspring. Together, these results suggest a pathologic role of monocytes in the two-hit (immune plus neonatal HI) model of neurodevelopmental defects.

Article

miR-26a Limits Muscle Wasting and Cardiac Fibrosis through Exosome-Mediated microRNA Transfer in Chronic Kidney Disease

by Bin Wang ; Ainqing Zhang; Haidong Wang; Janet D Klein; Lin Tan; Ze-Mu Wang; Jie Du; Nawazish Naqvi; Bi-Cheng Liu; Xiaonan Wang

2019

Subjects
  • Health Sciences, Medicine and Surgery
  • File Download
  • View Abstract

Abstract:Close

Uremic cardiomyopathy and muscle atrophy are associated with insulin resistance and contribute to chronic kidney disease (CKD)-induced morbidity and mortality. We hypothesized that restoration of miR-26a levels would enhance exosome-mediated microRNA transfer to improve muscle wasting and cardiomyopathy that occur in CKD. Methods: Using next generation sequencing and qPCR, we found that CKD mice had a decreased level of miR-26a in heart and skeletal muscle. We engineered an exosome vector that contained Lamp2b, an exosomal membrane protein gene fused with a muscle-specific surface peptide that targets muscle delivery. We transfected this vector into muscle satellite cells and then transduced these cells with adenovirus that expresses miR-26a to produce exosomes encapsulated miR-26a (Exo/miR-26a). Exo/miR-26a was injected once per week for 8 weeks into the tibialis anterior (TA) muscle of 5/6 nephrectomized CKD mice. Results: Treatment with Exo/miR-26a resulted in increased expression of miR-26a in skeletal muscle and heart. Overexpression of miR-26a increased the skeletal muscle cross-sectional area, decreased the upregulation of FBXO32/atrogin-1 and TRIM63/MuRF1 and depressed cardiac fibrosis lesions. In the hearts of CKD mice, FoxO1 was activated, and connective tissue growth factor, fibronectin and collagen type I alpha 1 were increased. These responses were blunted by injection of Exo/miR-26a. Echocardiograms showed that cardiac function was improved in CKD mice treated with Exo/miR-26a. Conclusion: Overexpression of miR-26a in muscle prevented CKD-induced muscle wasting and attenuated cardiomyopathy via exosome-mediated miR-26a transfer. These results suggest possible therapeutic strategies for using exosome delivery of miR-26a to treat complications of CKD.
Site Statistics
  • 35,724
  • Total Works
  • 9,167,302
  • Downloads
  • 245,176
  • Downloads This Year

Copyright © 2016 Emory University - All Rights Reserved
540 Asbury Circle, Atlanta, GA 30322-2870
(404) 727-6861
Privacy Policy | Terms & Conditions

v2.2.8-dev

Contact Us
Download now